TETRAPHARM appoints Rolf Sass Sørensen as Chief Executive Officer
Rolf Sass Sørensen succeeds co-founder Martin Rose. Founders Martin Rose and Jesper Breum move on to pursue new biotech ventures while remaining shareholders in TETRAPHARM. COPENHAGEN, Denmark, Oct. 9, 2026 /PRNewswire/ -- TETRAPHARM has appointed Rolf Sass Sørensen as Chief Executive...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.